This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Transactions

Oct. 24, 2000

Wilson Sonsini: HAYWARD GENETICS COMPANY GIVES LIFE TO $70 MILLION IPO

Hayward's Kosan Biosciences Inc. has gone public in an offering valued at $70 million. Kosan Biosciences is a development-stage genetics company that improves existing pharmaceuticals and develops new ones. Its gene manipulation process mimics, accelerates and expands the evolutionary process.

        Hayward's Kosan Biosciences Inc. has gone public in an offering valued at $70 million.
        Kosan Biosciences is a development-stage genetics company that improves existing pharmaceuticals and develops new ones. Its gene manipulation process mimics, accelerates and expands the evolutionary process. Kosan's products include antibiotics, anti-cancer drugs, cholesterol-lowering drugs, i...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up